Keith Woods

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Boston, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Zoran Zdraveski, Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Keith Woods

Form 4 holding Director

ROCKET PHARMACEUTICALS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
23,944
Estimated value
$360,118
Report date
13 Jun 2024
Price
$15.04
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Operating Officer

Scholar Rock Holding Corp

Security class
Stock Option (Right to Buy)
Shares / value
110,067
Estimated value
Report date
02 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Neurogene Inc.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
12,050
Estimated value
Report date
20 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Keith Woods

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .